Please login to the form below

BOLDSCIENCE marks its 1-year launch anniversary with record growth

Specialist medical communication agency BOLDSCIENCE has seen demand for its ‘scientifically creative’ service offerings soar over the past year as global pharma and biotech clients search for trusted partners with fresh ideas.

One year from launch, medical communications agency BOLDSCIENCE is celebrating a year of record growth exceeding 700%. The ‘scientifically creative’ agency has rapidly established a strong foothold with over 20 blue-chip pharma and biotech clients. It now has more than 75 staff working across the UK and in nine US states.

The agency markets itself on a ‘scientifically creative’ platform – offering a unique blend of high-science and world-class creative and digital innovation, within a people-focused culture. Their winning approach has been well received by the industry, with BOLDSCIENCE now supporting top pharma and biotech clients with strategic, medical, and commercial services.

BOLDSCIENCE is on course to achieve fee income growth exceeding 700% in its second full year of business. The growth is driven purely by new account wins and organic expansion, leading to diversification of the agency’s client base and therapeutic areas.

Commenting on a blockbusting year, Mark Lydiatt, BOLDSCIENCE’s Chief Executive Officer, says “We have seen immense interest in our services, driven by our staff’s passion and experience to deliver innovation, BOLD thinking, and high-quality service. We have been awarded preferred agency status with five top 20 pharma clients and are working on more than 30 cutting-edge products and compounds, many of which have the potential to radically change how some diseases will be managed. Our growth is unprecedented and is something we are immensely proud of."

“One of the greatest compliments that we receive is when prospective or current clients recognize that our ideas are fresh and exciting… ” says Mark Hardy, Chief Creative Officer. “We set out to push the boundaries of medcomms. We search for opportunities to introduce technology used in other industries into pharma and serve it up with our unique blend of science and creativity.”

Yasmin Grant, Chief Operating Officer, attributes their ability to attract top talent as the driving force behind BOLDSCIENCE’S accelerated trajectory. “Our staff are at the top of their game and the center of our agency. Our success is their success – we’re all one family”.

Looking to the future, BOLDSCIENCE plans to build on its successful start by continuing to deliver a premium service to its established clients. BOLDSCIENCE also has plans to offer an extended suite of strategic offerings beyond the traditional full-service agency capabilities.

“We’re excited about what the future holds – our plans will ultimately allow BOLDSCIENCE to offer our clients an unrivaled integrated strategic approach to support product communications, development, and commercialization strategy. We believe this will enrich all our offerings and allow career-development opportunities for our staff. We look forward to sharing our plans in the coming months,” says Alison Lovibond, Chief Scientific Officer.

For further information, please visit, or contact us at

10th September 2021



Company Details


+1 609-888-6071

Contact Website

18 Crucifix Lane
United Kingdom